AllSight
Companies · EYPT · Laboratory Analytical Instruments

EyePoint, Inc. (EYPT)

EyePoint, Inc. (EYPT) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

EyePoint, Inc. (EYPT) stock — financials & valuation

Key numbers for EyePoint, Inc. (EYPT): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 28/100 — a percentile rank of EyePoint, Inc.’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.

Market cap$431.9M
P / S154.9×
EV / EBITDA-1.0×
Gross margin41.8%
Operating margin-11365.2%
Net margin-10994.7%
Return on equity-184.4%
ROIC-566.8%
Revenue growth-94.6%
Debt / equity0.0×
Dividend yield0.0%

Is EyePoint, Inc. overvalued? P/S looks overvalued vs its 5-year range; P/B looks fair vs its 5-year range.

Independent of the events above — derived from EyePoint, Inc.’s own financial statements and shown as context, never as advice.

Aug 17, 2026Below the bar
A 4% anomaly turned a pivotal win into an endpoint miss
Aug 5, 2026
DME enrollment finishes early, but pivotal wet-AMD data remain pending.
Related companies in Laboratory Analytical Instruments
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact